Hong Kong Pharma Digital Technology Holdings LTD

F-120-F13D13G

Schedule 13D - Activist Investments

NASDAQ
Liying Wang, through TUTU Business Services Limited, has acquired a 65% controlling stake in Hong Kong Pharma Digital Technology Holdings Limited, triggering a significant management overhaul.

Schedule 13G - Passive Investments

NASDAQ
Atlantic Health Century International Group has reported a beneficial ownership of 5.62% in Hong Kong Pharma Digital Technology Holdings Ltd, holding 617,850 ordinary shares as of March 31, 2025.
NASDAQ
Pacific Health Century International Group has filed a Schedule 13G, disclosing beneficial ownership of 5.62% of Hong Kong Pharma Digital Technology Holdings Ltd's Ordinary Shares as of March 31, 2025.
NASDAQ
Lap Sun Wong and affiliated entities have disclosed beneficial ownership of 56.77% of Hong Kong Pharma Digital Technology Holdings Limited's Ordinary Shares.